Alamar Biosciences
Pre-clinicalDevelops ultrasensitive proteomics platforms for early disease detection and biomarker discovery.
Founded
2018
Focus
Diagnostics
About
Develops ultrasensitive proteomics platforms for early disease detection and biomarker discovery.
Funding History
5Total raised: $250.3M
Series B$80MNorthpond VenturesMay 15, 2023
Series B$100MKhosla VenturesOct 15, 2022
Series A$40MKhosla VenturesSep 15, 2021
Series A$30MKhosla VenturesApr 15, 2021
Company Info
TypePrivate
Founded2018
LocationFremont, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile